Stock Events

Stock Events

Apontis Pharma 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

1.56%Profit Margin
Profitable
2020
2021
2022
2023
2024
48.47MRevenue
754,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap301.95B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Apontis Pharma in various therapeutic areas.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Apontis Pharma's offerings, especially in the prescription drug market.
Merck
MRK
Mkt Cap376.37B
Merck & Co., Inc. is known for its innovative medicines and vaccines, competing with Apontis Pharma in areas such as healthcare and pharmaceuticals.
GSK
GSK
Mkt Cap104.97B
GlaxoSmithKline is a global healthcare company that produces pharmaceuticals and vaccines, competing with Apontis Pharma in multiple therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap651.25B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, making it a competitor across several of Apontis Pharma's business lines.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie is a research-based biopharmaceutical company that competes with Apontis Pharma in developing and marketing advanced therapies.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Apontis Pharma.
Sanofi
SNY
Mkt Cap109.86B
Sanofi is a global healthcare leader that discovers, develops, and distributes therapeutic solutions, competing with Apontis Pharma in the pharmaceutical sector.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics, directly competing with Apontis Pharma in the healthcare market.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Apontis Pharma in developing and commercializing prescription medicines.

About

Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.
Show more...
CEO
Mr. Thomas Milz
Employees
137
Country
Germany
ISIN
DE000A3CMGM5
WKN
000A3CMGM

Listings

MU
DE
APPH.MU

0 Comments

Share your thoughts

FAQ

What is Apontis Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Apontis Pharma stocks are traded under the ticker APPH.MU.
What is Apontis Pharma revenue for the last year?▼
Apontis Pharma revenue for the last year amounts to 48.47M EUR.
What is Apontis Pharma net income for the last year?▼
APPH.MU net income for the last year is 754,000 EUR.
How many employees does Apontis Pharma have?▼
As of August 25, 2026, the company has 137 employees.
In which sector is Apontis Pharma located?▼
Apontis Pharma operates in the Health & Wellness sector.
When did Apontis Pharma complete a stock split?▼
Apontis Pharma has not had any recent stock splits.
Where is Apontis Pharma headquartered?▼
Apontis Pharma is headquartered in Monheim am Rhein, Germany.